Evidence map›Paper›PMID 39390477›Full record

ArticleJournal of translational medicine2024

Multi-omics analysis reveals phenylalanine enhance mitochondrial function and hypoxic endurance via LKB1/AMPK activation.

Yi Wu, Yi Ma, Qiang Li, Jing Li, Di Zhang, Yuxin Zhang, Yue Li, Xiaorong Li, Pingxiang Xu, Lu Bai and 2 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Disrupted glutamate-gaba balance in children with adenoid hypertrophy:a targeted metabolomic and clinical correlation study.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2026
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yi Wu *Department of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Yi Ma *Department of Pharmacy, Peking University Third Hospital, Beijing, 100191, China.
Qiang LiDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Jing LiDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Di ZhangDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Yuxin ZhangDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Yue LiDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Xiaorong LiDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Pingxiang XuDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Lu BaiDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China.
Xuelin ZhouDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China. zhouxuelin@ccmu.edu.cn.
Ming XueDepartment of Pharmacology, School of Basic Medical Sciences, Capital Medical University, Beijing, 100069, China. xuem@ccmu.edu.cn.

Funding

Key Technologies Research and Development Program of Anhui Province 2021YFE0202700National Natural Science Foundation of China 81573683National Natural Science Foundation of China 81773803National Natural Science Foundation of China 82073925
6 · The paper itself

Abstract

Many studies have focused on the effects of small molecules, such as amino acids, on metabolism under hypoxia. Recent findings have indicated that phenylalanine levels were markedly elevated in adaptation to chronic hypoxia. This raises the possibility that phenylalanine treatment could markedly improve the hypoxic endurance. However, the importance of hypoxia-regulated phenylalanine is still unclear. This study investigates the role of phenylalanine in hypoxia adaptation using a hypoxic zebrafish model and multi-omics analysis. We found that phenylalanine-related metabolic pathways are significantly up-regulated under hypoxia, contributing to enhanced hypoxic endurance. Phenylalanine treatment reduced ROS levels, improved mitochondrial oxygen consumption rate (OCR), and extracellular acidification rate (ECAR) in hypoxic cells. Western blotting revealed increased phenylalanine uptake via L-type amino transporters (LAT1), activating the LKB1/AMPK signaling pathway. This activation up-regulated peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PGC-1α) and the Bcl-2/Bax ratio, while down-regulating uncoupling protein 2 (UCP2), thereby improving mitochondrial function under hypoxia. This is the first comprehensive multi-omics analysis to demonstrate phenylalanine's crucial role in hypoxia adaptation, providing insights for the development of anti-hypoxic drugs.

Indexed as

AMP-Activated Protein KinasesMitochondriaPhenylalanineProtein Serine-Threonine KinasesZebrafishAdaptation, PhysiologicalAMP-Activated Protein Kinase KinasesAnimalsEnzyme ActivationGenomicsHumansHypoxiaMultiomicsOxygen ConsumptionReactive Oxygen SpeciesSignal TransductionAMP-Activated Protein Kinase KinasesAMP-Activated Protein KinasesPhenylalanineProtein Serine-Threonine KinasesReactive Oxygen SpeciesAMPKHypoxia adaptionLAT1LKB1Mitochondrial functionMulti-omicsPhenylalanineROSZebrafish model

Identifiers

PMID39390477
PMCPMC11465566

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.